image: Scientists at Los Alamos National Laboratory have developed methods to quantify how much more or less transmissible new COVID variants are, which could have far-reaching implications for public health in terms of COVID-19 risk and the vaccination levels required to obtain herd immunity. Shown above, frequency of the B.1.1.7 strain in the UK (black dots) with the model prediction (blue line) assuming a transmission advantage of 45% over the baseline. view more
Credit: Los Alamos National Laboratory
LOS ALAMOS, N.M., December 22— As the discovery of the new omicron variant illustrates, new COVID-19 variants will continue to regularly emerge. In an effort to make sense of these new variants, scientists at Los Alamos National Laboratory have developed methods to quantify how much more or less transmissible they are, which could have far-reaching implications for public health in terms of COVID-19 risk and the vaccination levels required to obtain herd immunity.
“Generally, new COVID-19 variants are simply discussed in terms of being more dangerous or spreading quicker than previous strains,” said Ethan Romero-Severson, a computational epidemiologist in Los Alamos’s Theoretical Division and senior author on the paper published today in Nature Communications. “We showed that it is possible to calculate new strains’ transmission advantage while accounting for alternative explanations such as migration and random genetic drift. Our collection of methods allows us to look both broadly at the global situation and in greater detail at specific countries using publicly available genetic sequence data.”
The Los Alamos research is “a method for integrating molecular epidemiological surveillance into surveillance systems using publicly available data streams,” Romero-Severson noted.
The team used two distinct but complementary approaches. The first is derived from classical population genetic methods that relate the increased transmissibility of a COVID-19 variant to the expected frequency of that variant in the population over time.
“We modified that model to include migration as a possible alternative explanation to increased transmissibility and implemented it in a hierarchical modeling framework that allowed us to estimate the unique selection effect for each variant in each country in which it appeared,” he said.
The second, more detailed method used a stochastic (allowing for uncertainty) epidemiological model to predict both the changes in COVID-19 variant frequencies and deaths over time, accounting for natural and random variation in the virus both between and within countries over time.
Together, these approaches showed that the pattern of emerging and rising COVID-19 variants globally was driven by large increases in the transmissibility of the virus over time. The methods also clearly established that early detection of variants of concern is possible even when the global frequency of new variants is as small as 5 percent.
The paper: Estimating the strength of selection for new SARS-CoV-2 variants, Nature Communications, 12/14/21
The funding: Los Alamos Laboratory Directed Research and Development, and the National Science Foundation.
About Los Alamos National Laboratory
Los Alamos National Laboratory, a multidisciplinary research institution engaged in strategic science on behalf of national security, is managed by Triad, a public service oriented, national security science organization equally owned by its three founding members: Battelle Memorial Institute (Battelle), the Texas A&M University System (TAMUS), and the Regents of the University of California (UC) for the Department of Energy’s National Nuclear Security Administration.
Los Alamos enhances national security by ensuring the safety and reliability of the U.S. nuclear stockpile, developing technologies to reduce threats from weapons of mass destruction, and solving problems related to energy, environment, infrastructure, health, and global security concerns.
LA-UR-21-31696
Journal
Nature Communications
Article Title
Estimating the strength of selection for new SARS-CoV-2 variants
Article Publication Date
14-Dec-2021